Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $3.25 Million - $6.04 Million
-25,700 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $5.8 Million - $9.47 Million
25,700 New
25,700 $6.53 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $27,295 - $46,495
-250 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $16,435 - $42,465
250 New
250 $994,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bain Capital Public Equity Management Ii, LLC Portfolio

Follow Bain Capital Public Equity Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.